JM

Jitender Mehta

Active Director Director DIN 00497672
DIN 00497672 First appointment Apr 1993 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Apr 1993
Shareholding value Locked Premium profile

About Jitender Mehta

Data last updated:

Jitender Mehta has 33 years in corporate governance. Holds Director role. Currently with 1 company, including Sam Jvc Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00497672
Primary Designation Director
First Appointment 28 Apr 1993
Oldest Company Age 33 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Director28 Apr 19931993Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sam Jvc Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jitender Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitender Mehta

Jitender Mehta has 33 years in corporate governance. Holds Director role. Currently with 1 company, including Sam Jvc Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Jitender Mehta is associated with 1 company as Director.

Jitender Mehta has expertise in General Business.

Jitender Mehta has 33 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available